April 26, 2023 | 9:00am PT / 12:00pm ET | Presented by Oxford Global


Advances in mass spectrometry resolution and sensitivity have enabled increasingly comprehensive views into the multitude of small molecule metabolites circulating in humans. These metabolites read out diverse host and environmental exposures that influence human health and may serve as critical biomarkers for driving early disease diagnostics, precision medicine approaches, and clinical trial optimization.

In this webinar, we will share how Sapient has established discovery-as-a-service approaches that utilize next-generation, high throughput mass spectrometry, advanced data analysis, and population-scale data assets across >100,000 individuals to enable robust discovery of biomarkers that can be used to align patients, disease biology, and therapeutic interventions for clinical trials.

You will learn about:

  • The role of small molecule biomarkers in providing insight into human disease biology and drug response
  • Technologies enabling rapid identification of small molecule biomarkers of biological processes, disease progression, and drug response, including for clinical trial optimization
  • Real-world examples of how Sapient’s small molecule biomarker discovery approaches have been used to advance clinical trials

Click here to register now!